In a phase 2b dose-ranging trial [FRONTIER 1 (NCT05223868)], adult participants with moderate-to-severe plaque psoriasis ( n = 255) were randomized to receive five different doses of oral icotrokinra (25 mg daily, 25 mg twice daily, 50 mg daily, 100 mg daily, or 100 mg twice daily) or placebo for 16 weeks [86]
He said he would like GLP-1s to eventually be made available to Medicare and Medicaid patients who are seeking obesity treatment after they have tried other ways to lose weight
For Mounjaro to be used safely and effectively, only the appropriate groups of people must take it
Over the past decade, peptide-based drugs have become one of the most commercially successful classes of medicines in modern pharmacology
The problem is how poorly we prepare for its real-world effects
After Starting GLP-1 Treatment: Follow your prescribed dosing schedule consistently